Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...
But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful ...
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy ...
4d
Hosted on MSNOzempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results